rare disease Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx Premium The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics. Pacific Biosciences, Care4Rare Canada Consortium Collaborate on Rare Disease Research The partners will use PacBio's HiFi long-read sequencing technology to study rare disease samples that have already been sequenced with short-read technology. Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business Given its dwindling cash position, the firm will phase out its COVID-19 testing business and streamline its footprint, resulting in up to €15 million in cost savings per year. Emmes, MedGenome Partner on Rare Disease Patient Data Registry Project The companies said the custom registries of rare disease patients' epidemiologic, phenotypic, and genomic data will support clinical trials. Whole-Genome Sequencing Shines for Rare Disease Diagnosis in 100K Genomes Pilot Study Researchers diagnosed 25 percent of rare disease cases in a whole-genome sequencing pilot study of almost 2,200 patients and thousands more family members. Nov 11, 2021 Genomenon, Inozyme Collaborate on MDx Effort for ENPP1 Deficiency Nov 3, 2021 Genomic Answers for Kids Team Releases Thousands of Genomes to Gain Insights Into Rare Diseases Premium Oct 27, 2021 GenomSys Gains CE Mark for New Genomic Analysis Software Oct 20, 2021 Rady Children's Team Presents Genomic Medicine Management Tool at ASHG Oct 20, 2021 New Rare Disease Risk Loci Uncovered With 23andMe Participant Data Sep 20, 2021 Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx Sep 9, 2021 Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study Sep 7, 2021 Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover Jul 21, 2021 Congenica Receives CE Mark for Clinical Decision Support Software Jul 15, 2021 Takeda Pharmaceutical, Rady Children's Partner on Rare Genetic Disease Drug Development Jul 1, 2021 ACMG Recommends Sequencing as Test for Children With Intellectual Disability, Congenital Anomalies Jun 23, 2021 Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Jun 14, 2021 Celemics, Strand Life Sciences Partner on Integrated Platform for NGS Analysis Jun 10, 2021 Nostos Genomics Aims to Ease Variant Interpretation Bottlenecks With AI Premium Jun 3, 2021 EHR-Based Model Predicts Patients Who May Benefit from Genetic Testing for Rare Disease Jun 1, 2021 Genomenon, Nostos Genomics to Integrate Technologies to Improve Rare Disease Dx Apr 19, 2021 Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Apr 15, 2021 Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing Apr 12, 2021 Sanford Health Looks to Improve Rare Disease Dx, Research With Congenica Technology Premium Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more. Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.